Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-22-133659
Filing Date
2022-04-29
Accepted
2022-04-29 16:10:49
Documents
8

Document Format Files

Seq Description Document Type Size
1 DEFA14A d294152ddefa14a.htm DEFA14A 31210
2 GRAPHIC g294152naa3.jpg GRAPHIC 707
3 GRAPHIC g294152naa4jpg.jpg GRAPHIC 35435
4 GRAPHIC g294152naa5.jpg GRAPHIC 4858
5 GRAPHIC g294152naa6.jpg GRAPHIC 6160
6 GRAPHIC g294152naa7.jpg GRAPHIC 1251
7 GRAPHIC g294152pc2.jpg GRAPHIC 4366
8 GRAPHIC g294152pc3.jpg GRAPHIC 32446
  Complete submission text file 0001193125-22-133659.txt   150524
Mailing Address 4721 EMPEROR BOULEVARD, SUITE 100 DURHAM NC 27703
Business Address 4721 EMPEROR BOULEVARD, SUITE 100 DURHAM NC 27703 (919) 474-6700
Bioventus Inc. (Filer) CIK: 0001665988 (see all company filings)

EIN.: 810980861 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37844 | Film No.: 22875419
SIC: 3841 Surgical & Medical Instruments & Apparatus